GRI Bio, Inc. GRI
NASDAQ · United States · Health Technology
$1.960.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.91 | -1.20 | +23.8% | $0 | — | -2.3%$1.77→$1.73 |
| Q1 2026 | 2026-05-13 | -1.61 | -0.91 | -76.9% | — | — | -5.7%$2.28→$2.15 |
| Q4 2025 | 2026-01-30 | -116.61 | -29.26 | -298.5% | — | — | -13.9%$3.32→$2.86 |
| Q3 2025 | 2025-11-14 | -35.84 | -31.08 | -15.3% | — | — | -5.3%$47.32→$44.80 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.